Life Science Leaders Meet at White House

Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.

By | May 8, 2017

FLICKR, DIEGO CAMBIOSOIndustry executives and Stanford University’s president made their case for supporting biotech investments at the White House’s biotech summit today (May 8). They bent the ears of Vice President Mike Pence, Health and Human Services Secretary Tom Price, National Institutes of Health Director Francis Collins, and advisors to President Trump.

“We spoke to the importance of maintaining the United States’ investment in biomedical research, and of retaining our global leadership in the field to keep jobs and expertise in the U.S.,” Marc Tessier-Levigne, Stanford’s president, said in a statement sent to The Scientist. “Members of the Administration were interested and engaged in our conversation. They have a deep understanding of global competitiveness in this sector.”

Bill Ford, CEO of the investment firm General Atlantic, told Bloomberg in a statement: “Following today’s discussion it is clear that the White House is committed to further extending America’s leadership position in this vital industry.”

The president signed a spending package last week (May 5) that gives the NIH a $2 billion infusion of additional appropriations to last through September. His proposed spending bill for 2018, however, includes a nearly 20 percent cut to the agency’s budget.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. Opinion: We Need a Replacement for Beall’s List
  3. Your Body Is Teeming with Weed Receptors
    Features Your Body Is Teeming with Weed Receptors

    And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

  4. Doctors’ Advice to Finish Antibiotics Overlooks Resistance